• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征中阿尔茨海默病的常见遗传特征。

Common genetic signatures of Alzheimer's disease in Down Syndrome.

机构信息

BioScience Project, PO Box 352, Wakefield, MA, 01880, USA.

Department of Biotechnology, Chaitanya Bharathi Institute of Technology, Hyderabad, 500075, India.

出版信息

F1000Res. 2020 Nov 5;9:1299. doi: 10.12688/f1000research.27096.2. eCollection 2020.

DOI:10.12688/f1000research.27096.2
PMID:33633844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7871416/
Abstract

People with Down Syndrome (DS) are born with an extra copy of Chromosome (Chr) 21 and many of these individuals develop Alzheimer's Disease (AD) when they age. This is due at least in part to the extra copy of the APP gene located on Chr 21. By 40 years, most people with DS have amyloid plaques which disrupt brain cell function and increase their risk for AD. About half of the people with DS develop AD and the associated dementia around 50 to 60 years of age, which is about the age at which the hereditary form of AD, early onset AD, manifests. In the absence of Chr 21 trisomy, duplication of APP alone is a cause of early onset Alzheimer's disease, making it likely that having three copies of APP is important in the development of AD and in DS. We investigate the relationship between AD and DS through integrative analysis of genesets derived from a MeSH query of AD and DS associated beta amyloid peptides, Chr 21, GWAS identified AD risk factor genes, and differentially expressed genes in individuals with DS.  Unique and shared aspects of each geneset were evaluated based on  functional enrichment analysis, transcription factor profile and network interactions. Genes that may be important to both disorders in the context of direct association with APP processing, Tau post translational modification  and network connectivity are ACSM1, APBA2, APLP1, BACE2, BCL2L, COL18A1, DYRK1A, IK, KLK6, METTL2B, MTOR, NFE2L2, NFKB1, PRSS1, QTRT1, RCAN1, RUNX1, SAP18 SOD1, SYNJ1, S100B. Our findings confirm that oxidative stress, apoptosis, inflammation and immune system processes likely contribute to the pathogenesis of AD and DS which is consistent with other published reports.

摘要

唐氏综合征(DS)患者的第 21 号染色体(Chr)存在额外的拷贝,其中许多个体在衰老时会发展为阿尔茨海默病(AD)。这至少部分归因于位于 Chr 21 上的 APP 基因的额外拷贝。到 40 岁时,大多数 DS 患者都有淀粉样斑块,这会破坏脑细胞功能并增加他们患 AD 的风险。大约一半的 DS 患者在 50 到 60 岁左右发展为 AD 和相关痴呆症,这大约是早发性 AD 这种遗传性 AD 形式表现出来的年龄。在没有 Chr 21 三体的情况下,仅 APP 的重复是早发性阿尔茨海默病的原因,这表明 APP 有三个拷贝对于 AD 和 DS 的发展很重要。我们通过对 AD 和 DS 相关的β淀粉样肽、Chr 21、GWAS 确定的 AD 风险因素基因和 DS 个体中差异表达基因进行 MeSH 查询的基因集的综合分析,研究 AD 和 DS 之间的关系。基于功能富集分析、转录因子谱和网络相互作用,评估了每个基因集的独特和共享方面。在与 APP 处理、Tau 翻译后修饰和网络连通性直接相关的背景下,可能对两种疾病都很重要的基因包括 ACSM1、APBA2、APLP1、BACE2、BCL2L、COL18A1、DYRK1A、IK、KLK6、METTL2B、MTOR、NFE2L2、NFKB1、PRSS1、QTRT1、RCAN1、RUNX1、SAP18、SOD1、SYNJ1、S100B。我们的研究结果证实,氧化应激、细胞凋亡、炎症和免疫系统过程可能有助于 AD 和 DS 的发病机制,这与其他已发表的报告一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/e6c645a98868/f1000research-9-78591-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/07570aa74b45/f1000research-9-78591-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/5ce04b0de4c4/f1000research-9-78591-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/2203cf7aa926/f1000research-9-78591-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/e6c645a98868/f1000research-9-78591-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/07570aa74b45/f1000research-9-78591-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/5ce04b0de4c4/f1000research-9-78591-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/2203cf7aa926/f1000research-9-78591-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5629/8546738/e6c645a98868/f1000research-9-78591-g0003.jpg

相似文献

1
Common genetic signatures of Alzheimer's disease in Down Syndrome.唐氏综合征中阿尔茨海默病的常见遗传特征。
F1000Res. 2020 Nov 5;9:1299. doi: 10.12688/f1000research.27096.2. eCollection 2020.
2
Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21.唐氏综合征 21 号染色体三体性对 APP 与淀粉样-β 生物学调节的遗传定位。
J Neurosci. 2022 Aug 17;42(33):6453-6468. doi: 10.1523/JNEUROSCI.0521-22.2022. Epub 2022 Jul 14.
3
BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.β-分泌酶2(BACE2)作为一种新型的淀粉样前体蛋白(APP)θ-分泌酶,与唐氏综合征中阿尔茨海默病的发病机制无关。
FASEB J. 2006 Jul;20(9):1369-76. doi: 10.1096/fj.05-5632com.
4
Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.人类 21 号染色体三体增加淀粉样-β沉积,而与 APP 的额外拷贝无关。
Brain. 2018 Aug 1;141(8):2457-2474. doi: 10.1093/brain/awy159.
5
[Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].[阐明唐氏综合征患者早发性阿尔茨海默病的致病机制]
Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2.
6
Amyloid-β precursor protein facilitates the regulator of calcineurin 1-mediated apoptosis by downregulating proteasome subunit α type-5 and proteasome subunit β type-7.淀粉样前体蛋白通过下调蛋白酶体亚基α5型和蛋白酶体亚基β7型来促进钙调神经磷酸酶1介导的细胞凋亡。
Neurobiol Aging. 2015 Jan;36(1):169-77. doi: 10.1016/j.neurobiolaging.2014.07.029. Epub 2014 Aug 7.
7
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.鉴定唐氏综合征和阿尔茨海默病患者脑中单体和可溶聚集态 Aβ。
Neurosci Lett. 2021 May 29;754:135894. doi: 10.1016/j.neulet.2021.135894. Epub 2021 Apr 10.
8
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.唐氏综合征小鼠模型中 Dyrk1A 基因剂量的正常化可挽救几种阿尔茨海默病表型。
Neurobiol Dis. 2017 Oct;106:76-88. doi: 10.1016/j.nbd.2017.06.010. Epub 2017 Jun 21.
9
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.唐氏综合征、21号染色体部分三体与阿尔茨海默病的缺失:淀粉样前体蛋白(APP)的作用
J Alzheimers Dis. 2017;56(2):459-470. doi: 10.3233/JAD-160836.
10
Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).唐氏综合征中的溶酶体功能障碍依赖于 APP,并且由 APP-βCTF(C99)介导。
J Neurosci. 2019 Jul 3;39(27):5255-5268. doi: 10.1523/JNEUROSCI.0578-19.2019. Epub 2019 May 1.

引用本文的文献

1
Recent Advances and Future Directions in Alzheimer's Disease Genetic Research.阿尔茨海默病遗传研究的最新进展与未来方向
Int J Mol Sci. 2025 Aug 13;26(16):7819. doi: 10.3390/ijms26167819.
2
Resistance and resilience to Alzheimer's disease in Down syndrome.唐氏综合征对阿尔茨海默病的抵抗力和恢复力
Alzheimers Dement. 2025 Apr;21(4):e70151. doi: 10.1002/alz.70151.
3
Causal Discovery with Generalized Linear Models through Peeling Algorithms.通过剥离算法利用广义线性模型进行因果发现
J Mach Learn Res. 2024;25.
4
RNAseq profiling of blood from patients with coronary artery disease: Signature of a T cell imbalance.冠心病患者血液的RNA测序分析:T细胞失衡特征
J Mol Cell Cardiol Plus. 2023 Jun;4. doi: 10.1016/j.jmccpl.2023.100033. Epub 2023 Mar 25.
5
Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning.使用基于因果关系的特征选择和机器学习进行肌萎缩侧索硬化症的基因靶向治疗。
Mol Med. 2023 Jan 24;29(1):12. doi: 10.1186/s10020-023-00603-y.
6
Triplication of in Alzheimer's Disease Pathology in Down Syndrome.唐氏综合征中阿尔茨海默病病理学中[具体内容]的三倍体现象 。(你原文中“Triplication of ”后面似乎缺失了关键信息)
Curr Alzheimer Res. 2022;19(12):795-807. doi: 10.2174/1567205020666221202102832.
7
Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome.唐氏综合征等基因背景皮质类器官模型中兴奋性神经元的异步发育
Front Neurosci. 2022 Sep 7;16:932384. doi: 10.3389/fnins.2022.932384. eCollection 2022.
8
Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes.新型冠状病毒肺炎中中枢和外周神经损伤与神经保护血清标志物的动态变化受不同类型抗病毒治疗的调节,但不影响早期和晚期中风的发生率。
Biomedicines. 2021 Nov 29;9(12):1791. doi: 10.3390/biomedicines9121791.
9
Towards a Consensus on Alzheimer's Disease Comorbidity?关于阿尔茨海默病合并症的共识?
J Clin Med. 2021 Sep 24;10(19):4360. doi: 10.3390/jcm10194360.
10
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview.双特异性酪氨酸磷酸化调节激酶(DYRKs)和细胞分裂周期 2 样激酶(CLKs)在人类疾病中的作用概述。
Int J Mol Sci. 2021 Jun 3;22(11):6047. doi: 10.3390/ijms22116047.